AETHLON MEDICAL INC
NASDAQ: AEMD (Aethlon Medical, Inc.)
Last update: 6 hours ago6.78
5.35 (374.13%)
| Previous Close | 1.43 |
| Volume | 92,174,162 |
| Price / Sales | 2.37 |
| Price / Book | 0.200 |
| 52 Weeks Range |
| Diluted EPS (TTM) | -8.58 |
| Total Debt/Equity (MRQ) | 16.16% |
| Current Ratio (MRQ) | 3.13 |
| Operating Cash Flow (TTM) | -7.65 M |
| Levered Free Cash Flow (TTM) | -4.89 M |
| Return on Assets (TTM) | -74.82% |
| Return on Equity (TTM) | -245.88% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Devices (US) | Mixed | Mixed |
| Medical Devices (Global) | Mixed | Mixed | |
| Stock | Aethlon Medical, Inc. | Mixed | Bearish |
AIStockmoo Score
| Analyst Consensus | NA |
| Insider Activity | NA |
| Price Volatility | -2.0 |
| Technical Moving Averages | 2.5 |
| Technical Oscillators | -0.5 |
| Average | 0.00 |
|
Aethlon Medical Inc is a medical therapeutic company focused on developing the Hemopurifier (HP), a clinical-stage investigational immunotherapeutic device designed to address unmet needs in oncology, life-threatening infectious diseases, organ transplantation and other disease states in which extracellular vesicles (EVs) contribute to disease progression. The Hemopurifier utilizes a proprietary lectin-based technology to bind and remove enveloped viruses and EVs from biological fluids. EVs have been associated with immune suppression, metastasis, and resistance to therapy in cancer, as well as progression of severe infectious diseases. The Company operates as a single reportable segment. |
|
| Sector | Healthcare |
| Industry | Medical Devices |
| Investment Style | Small Value |
| % Held by Insiders | 0.56% |
| % Held by Institutions | 16.25% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Scientech Research Llc | 30 Jun 2026 | 2,011 |
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |